Rinri Therapeutics lands seed funding
UK-based Rinri Therapeutics, a biotech company, has secured 1.4 million pounds in seed funding. Boehringer Ingelheim Venture Fund and UCB Ventures led the round with participation from BioCity.
20 May 2019•5 mins read
